NeuroPace Inc. (NPCE) CEO With A Company Overview

<p>The president and CEO of Neuropace Inc. (NPCE), Mike Favet, says that the commercial-stage medical device company created a RNS System for drug-resistant epilepsy. The stock began publicly trading today with shares opening for trade at $23.25 per share. </p>